These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 10984368

  • 1. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma.
    Kemp JP, Berkowitz RB, Miller SD, Murray JJ, Nolop K, Harrison JE.
    J Allergy Clin Immunol; 2000 Sep; 106(3):485-92. PubMed ID: 10984368
    [Abstract] [Full Text] [Related]

  • 2. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma.
    Corren J, Berkowitz R, Murray JJ, Prenner B.
    Int J Clin Pract; 2003 Sep; 57(7):567-72. PubMed ID: 14529054
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.
    D'Urzo A, Karpel JP, Busse WW, Boulet LP, Monahan ME, Lutsky B, Staudinger H.
    Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538
    [Abstract] [Full Text] [Related]

  • 4. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler.
    Noonan M, Karpel JP, Bensch GW, Ramsdell JW, Webb DR, Nolop KB, Lutsky BN.
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):36-43. PubMed ID: 11206236
    [Abstract] [Full Text] [Related]

  • 5. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma.
    Nayak AS, Banov C, Corren J, Feinstein BK, Floreani A, Friedman BF, Goldsobel A, Gottschlich GM, Hannaway PJ, Lampl KL, Lapidus RJ, Lawrence M, Lumry W, Munk Z, Pearlman D, Scardella AT, Schenkel EJ, Segal AT, Segall N, Silverman B, Shneyer L, Nolop KB, Harrison JE.
    Ann Allergy Asthma Immunol; 2000 Apr; 84(4):417-24. PubMed ID: 10795650
    [Abstract] [Full Text] [Related]

  • 6. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.
    Karpel JP, Busse WW, Noonan MJ, Monahan ME, Lutsky B, Staudinger H.
    Ann Pharmacother; 2005 Dec; 39(12):1977-83. PubMed ID: 16264062
    [Abstract] [Full Text] [Related]

  • 7. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
    O'Connor B, Bonnaud G, Haahtela T, Luna JM, Querfurt H, Wegener T, Lutsky BN.
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
    [Abstract] [Full Text] [Related]

  • 8. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
    Bensch GW, Prenner B, Berkowitz R, Galant S, Ramsdell J, Lutsky B.
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
    [Abstract] [Full Text] [Related]

  • 9. Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate.
    Nathan RA, Nayak AS, Graft DF, Lawrence M, Picone FJ, Ahmed T, Wolfe J, Vanderwalker ML, Nolop KB, Harrison JE.
    Ann Allergy Asthma Immunol; 2001 Feb; 86(2):203-10. PubMed ID: 11258691
    [Abstract] [Full Text] [Related]

  • 10. Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma.
    Holgate ST, Arshad H, Stryszak P, Harrison JE.
    J Allergy Clin Immunol; 2000 May; 105(5):906-11. PubMed ID: 10808170
    [Abstract] [Full Text] [Related]

  • 11. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma.
    Berger WE, Milgrom H, Chervinsky P, Noonan M, Weinstein SF, Lutsky BN, Staudinger H.
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):672-80. PubMed ID: 17165278
    [Abstract] [Full Text] [Related]

  • 12. Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler.
    Zetterström O, Dahl R, Lindqvist A, Olsson P.
    Respir Med; 2008 Oct; 102(10):1406-11. PubMed ID: 18640826
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
    Wardlaw A, Larivee P, Eller J, Cockcroft DW, Ghaly L, Harris AG.
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
    [Abstract] [Full Text] [Related]

  • 14. Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma.
    Zeidler M, Corren J, Tashkin DP.
    Curr Med Res Opin; 2010 Jun; 26(6):1295-305. PubMed ID: 20370376
    [Abstract] [Full Text] [Related]

  • 15. Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthma.
    Karpel J, D'urzo A, Lockey RF.
    J Asthma; 2008 Nov; 45(9):747-53. PubMed ID: 18972289
    [Abstract] [Full Text] [Related]

  • 16. Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma.
    Skoner DP, Meltzer EO, Milgrom H, Stryszak P, Teper A, Staudinger H.
    J Asthma; 2011 Oct; 48(8):848-59. PubMed ID: 21854342
    [Abstract] [Full Text] [Related]

  • 17. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
    Karpel JP, Nayak A, Lumry W, Craig TJ, Kerwin E, Fish JE, Lutsky B.
    Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
    [Abstract] [Full Text] [Related]

  • 18. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
    Harnest U, Price D, Howes T, Sussman G.
    J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
    [Abstract] [Full Text] [Related]

  • 19. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
    Fish JE, Karpel JP, Craig TJ, Bensch GW, Noonan M, Webb DR, Silverman B, Schenkel EJ, Rooklin AR, Ramsdell JW, Nathan R, Leflein JG, Grossman J, Graft DF, Gower RG, Garay SM, Frigas E, Degraff AC, Bronsky EA, Bernstein DI, Berger W, Shneyer L, Nolop KB, Harrison JE.
    J Allergy Clin Immunol; 2000 Nov; 106(5):852-60. PubMed ID: 11080706
    [Abstract] [Full Text] [Related]

  • 20. Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma.
    Karpel JP, Nelson H.
    Curr Med Res Opin; 2007 Nov; 23(11):2897-911. PubMed ID: 17922978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.